ArticleBMJ open2022

AOZORA: long-term safety and joint health in paediatric persons with haemophilia A without factor VIII inhibitors receiving emicizumab - protocol for a multicentre, open-label, phase IV clinical study.

Midori Shima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.